Seres Therapeutics Sponsored Webinar: The Latest in Management and Prevention of Recurrent Clostridioides difficile infection (CDI)

Seres Therapeutics Sponsored Webinar: The Latest in Management and Prevention of Recurrent Clostridioides difficile infection (CDI)

Product not yet rated

Recorded On: 05/02/2023

Webinar Description: 

In this sponsored webinar, the presenter will review diagnostic techniques and management strategies for patients with recurrent Clostridioides difficile infection (CDI) including the evolving use of live biotherapeutic products. It is critical that healthcare professionals are able to appropriately diagnose and manage recurrent CDI, as CDI, like any infection, can lead to sepsis and other complications.

No CE credits are offered for this sponsored webinar. Content was determined by the sponsor.

Webinar Sponsor: 

Sepsis Alliance gratefully acknowledges the support provided by Seres Therapeutics for this sponsored webinar.

image


Jessica R. Allegretti, MD, MPH, FACG

Medical Director, Crohn's and Colitis Center; Director, FMT Program

Brigham and Women's Hospital

Jessica Allegretti, MD, MPH, FACG, currently serves as the Medical Director of the Crohn’s and Colitis Center at the Brigham and Women’s Hospital. She developed and leads the hospital’s Fecal Microbiota Transplantation Program and is an international expert on the topic.

Maryann Webb

Recurrent C. Diff Survivor

Maryann Webb is a survivor of recurrent C. diff and will share her journey of how this common infection impacted her life and those of her family and friends. She will describe how she turned her difficult journey into advocacy for others affected with C. diff and for the development of new treatments for this infection.

Components visible upon registration.